The interventional oncology market is experiencing significant growth as healthcare providers increasingly adopt minimally invasive procedures for cancer diagnosis and treatment. The global interventional oncology market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 5.6 billion by 2033, at a CAGR of 8.6% from 2026 to 2033. The market in North America dominated with a revenue share of 41.8% in 2025. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology.

The increasing adoption of image-guided procedures, advanced medical devices, and targeted treatment approaches is supporting market expansion. Interventional oncology techniques enable precise cancer treatment with reduced recovery time, improved patient outcomes, and lower procedural risks compared with conventional treatment methods. Rising demand for personalized cancer care and continuous innovation in oncology devices are further encouraging healthcare organizations to invest in advanced interventional solutions.

Download a free sample copy of the Interventional Oncology market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

Regional analysis indicates that North America dominated the interventional oncology market, accounting for the largest revenue share of 41.8% in 2025. The region’s leadership is supported by advanced healthcare infrastructure, high adoption of minimally invasive cancer treatments, strong presence of medical device companies, increasing cancer research investments, and favorable healthcare systems. Furthermore, Asia Pacific is expected to register the highest CAGR from 2026 to 2033, driven by rising cancer prevalence, improving healthcare infrastructure, growing medical technology adoption, and increasing investments in oncology care.
Based on technique, the ablation therapies segment held the largest market share in 2025. Ablation therapies are widely adopted due to their effectiveness in targeting tumors with minimal damage to surrounding tissues, shorter recovery periods, and increasing application across various cancer treatments.
Based on procedures, the vascular interventions segment held the largest market share of 38.1% in 2025. The segment growth is supported by increasing use of embolization procedures, improved treatment precision, and growing demand for minimally invasive approaches in cancer management.
Based on application, the liver cancer segment held the largest market share of 27.8% in 2025. The segment dominance is attributed to the increasing prevalence of liver cancer, rising adoption of targeted therapies, and growing utilization of interventional procedures for tumor management.
Based on end-use, the hospitals segment held the largest market share of 55.3% in 2025. Hospitals remain the leading end users due to availability of advanced medical equipment, specialized oncology departments, skilled healthcare professionals, and comprehensive cancer treatment facilities.
By country, the U.S. held the largest market share in 2025. The country’s leadership is supported by advanced oncology research, strong healthcare infrastructure, increasing adoption of innovative treatment technologies, and high investments in cancer care solutions.

Key Companies & Market Share Insights

The interventional oncology market is competitive, with leading companies focusing on expanding product portfolios, improving treatment technologies, and strengthening their global presence through strategic initiatives. Market participants are implementing expansion activities, partnerships, and collaborations to increase product accessibility and enhance their position in the evolving oncology treatment landscape.

Companies operating in the market are investing in advanced interventional devices, image-guided technologies, and minimally invasive treatment solutions to address the growing demand for effective cancer care options. Strategic partnerships between healthcare organizations, medical device manufacturers, and research institutions are helping accelerate innovation and improve patient access to advanced oncology procedures.

The increasing focus on early cancer detection, precision-based treatment methods, and minimally invasive procedures is encouraging companies to develop next-generation technologies. These initiatives are expected to support market growth by improving treatment efficiency, expanding clinical applications, and enhancing cancer care outcomes.

With rising cancer incidence, growing geriatric population, increasing investments in oncology research, and continuous advancements in minimally invasive procedures, the interventional oncology market is expected to experience sustained growth through 2033. Companies focusing on technological innovation, strategic collaborations, and expanded healthcare access are well positioned to capitalize on emerging opportunities in the oncology sector.

Key Interventional Oncology Companies:

Medtronic plc
Boston Scientific Corporation
Johnson & Johnson (Ethicon)
Teleflex Incorporated

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Grand View Research offers

Focused market intelligence reports on specific geographies or high-growth segments.
Extended forecast timelines for long-term planning.
Competitor Benchmarking and Supply Chain Analysis
Inclusion of regulatory and policy assessments.
Inclusion of custom data models, KPIs, or applications unique to your business
Specific high-impact Data Decks and Tables to support effective decision making
And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Minimally Invasive Technologies Transform the Interventional Oncology Market

The global interventional oncology market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 5.6 billion